On August 21, COMPAL Group's Chairman Ray Chen and Chief Sustainability Officer Eric Peng, along with the Shin Pao Medical team, visited Shin Kong Hospital to participate in the signing ceremony of the "Memorandum of Cooperation" between COMPAL and Shin Kong Hospital. This event marks the official commencement of a collaborative medical AI development plan, aimed at actively expanding the medical business into overseas markets in North America, Europe, and Southeast Asia, while accelerating the application of AI technology to provide tangible medical services globally.
【From left: Compal Chairman Ray Chen, Shin Kong Hospital Director Hou Shengmao】
Chairman Ray Chen expressed, "COMPAL is continuously enhancing its commitment to smart healthcare. Besides precision medicine, we are proactively integrating AI technologies to address public needs. Currently, we have launched AI solutions for common health issues, including risk assessment for frozen shoulder, brainwave-based stress evaluation, and hearing assessments. Looking ahead, we will persist in the development of various AI medical devices to bolster hospital computing capabilities." Director Hou Shengmao of Shin Kong Hospital stated, "The collaboration between Shin Kong Hospital and COMPAL will initiate with AI-driven quantitative analysis of lung fibrosis in medical imaging. By employing high-resolution computed tomography scans for AI analysis, we aim to enhance the efficiency of traditional semi-quantitative evaluations, improve accuracy in disease assessments, and reduce annotation times. COMPAL will supply AI PC equipment, while the radiology team at Shin Kong Hospital will provide AI models and validation in real-world settings to enhance public health outcomes."
This partnership seeks to ensure that limited medical resources are not hindered by geographical constraints, allowing deeper engagement with community residents in underserved areas. With the trust of patients, skilled medical teams will harness AI medical imaging technologies to optimize treatment timelines and improve diagnostic accuracy, thereby broadening the application of AI in cross-border healthcare services.
COMPAL remains dedicated to fostering technological innovation, prioritizing the cultivation of professional talent, and implementing sustainable practices in line with ESG principles. The unwavering commitment of COMPAL’s exceptional partners to ongoing research and development, along with strategic initiatives to diversify operations and advance smart healthcare products, aims to benefit a larger global audience while generating long-term shared value for the company and its stakeholders.
News Link:
https://www.ctee.com.tw/news/20240821700655-430502
https://www.chinatimes.com/realtimenews/20240821002199-260418?chdtv
https://www.moneydj.com/kmdj/news/newsviewer.aspx?a=45db1d84-dcf4-43f2-89f8-03f0126bd6d6
https://www.ctee.com.tw/news/20240821700655-430502
https://udn.com/news/story/7266/8176348
https://money.udn.com/money/story/5612/8175782
https://finance.ettoday.net/news/2801563